Published ahead of print on July 14, 2005, doi:10.1164/rccm.200504-663OE
Am. J. Respir. Crit. Care Med., Volume 172, Number 7, October 2005, 798-806
A more recent version of this article appeared on October 1, 2005
Submitted on April 27, 2005
Accepted on July 14, 2005
Acute Respiratory Distress Syndrome: A Historical Perspective
Gordon R Bernard1*
1 Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University, Nashville, TN, United States
* To whom correspondence should be addressed. E-mail: gordon.bernard{at}vanderbilt.edu.
Though well described even in ancient writings, the Acute Respiratory Distress Syndrome (ARDS) gained major medical attention with the availability of mechanical ventilation and establishment of intensive care units. In the fifty years since this beginning there have been remarkable advances in the understanding of the etiology, physiology, histology and epidemiology of this often lethal complication of common human maladies. Until recently, improvements in outcome have mainly followed improvements in intensive care unit operation and their associated life support systems and not through discoveries made in the course of prospective randomized trials. In spite of the remarkable increase in research focused on ARDS, there remain a large number of unanswered clinical questions that are potentially extremely important with regard to short term morbidity as well as long term outcome. The ARDS Clinical Trials Network study of tidal volume has proven that randomized trials in ARDS with positive results are possible even when using difficult primary outcome measures such as mortality or ventilator free days. Therefore the rich combination of new trial strategies, potential treatments, experienced investigators and increasingly standardized routine care, set the stage for rapid advances to be made in the short and long-term outcomes of this devastating syndrome.
Key words: ARDS, Acute lung injury, non-cardiogenic pulmonary edema, Acute respiratory distress syndrome, Adult respiratory distress syndrome, acute lung injury
This article has been cited by other articles:

|
 |

|
 |
 
C. G. Clement, S. E. Evans, C. M. Evans, D. Hawke, R. Kobayashi, P. R. Reynolds, S. J. Moghaddam, B. L. Scott, E. Melicoff, R. Adachi, et al.
Stimulation of Lung Innate Immunity Protects against Lethal Pneumococcal Pneumonia in Mice
Am. J. Respir. Crit. Care Med.,
June 15, 2008;
177(12):
1322 - 1330.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Zambon and J.-L. Vincent
Mortality Rates for Patients With Acute Lung Injury/ARDS Have Decreased Over Time
Chest,
May 1, 2008;
133(5):
1120 - 1127.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Holzinger, M. Feldbacher, A. Bachlechner, R. Kitzberger, V. Fuhrmann, and C. Madl
Improvement of Glucose Control in the Intensive Care Unit: An Interdisciplinary Collaboration Study
Am. J. Crit. Care.,
March 1, 2008;
17(2):
150 - 156.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. D. Girard and G. R. Bernard
Mechanical Ventilation in ARDS: A State-of-the-Art Review
Chest,
March 1, 2007;
131(3):
921 - 929.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. H. Savel, E. B. Goldstein, E. N. Perencevich, and P. B. Angood
The iCritical Care Podcast: A Novel Medium for Critical Care Communication and Education
J. Am. Med. Inform. Assoc.,
January 1, 2007;
14(1):
94 - 99.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Xu, J. Qiao, L. Zhao, G. Wang, G. He, K. Li, Y. Tian, M. Gao, J. Wang, H. Wang, et al.
Acute Respiratory Distress Syndrome Induced by Avian Influenza A (H5N1) Virus in Mice
Am. J. Respir. Crit. Care Med.,
November 1, 2006;
174(9):
1011 - 1017.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. G. Parambil, J. L. Myers, and J. H. Ryu
Diffuse alveolar damage: uncommon manifestation of pulmonary involvement in patients with connective tissue diseases.
Chest,
August 1, 2006;
130(2):
553 - 558.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R F Miller, E Allen, A Copas, M Singer, and S G Edwards
Improved survival for HIV infected patients with severe Pneumocystis jirovecii pneumonia is independent of highly active antiretroviral therapy
Thorax,
August 1, 2006;
61(8):
716 - 721.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. B. Milbrandt, A. Ishizaka, and D. C. Angus
Update in critical care 2005.
Am. J. Respir. Crit. Care Med.,
April 15, 2006;
173(8):
833 - 841.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Matthay and E. Abraham
beta-Adrenergic Agonist Therapy as a Potential Treatment for Acute Lung Injury
Am. J. Respir. Crit. Care Med.,
February 1, 2006;
173(3):
254 - 255.
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 American Thoracic Society
|
|
|